Haleon (NYSE:HLN) Stock Price Down 3.4% - Time to Sell?

Shares of Haleon plc (NYSE:HLN - Get Free Report) were down 3.4% on Tuesday . The company traded as low as $11.01 and last traded at $11.02. Approximately 15,858,390 shares traded hands during mid-day trading, an increase of 85% from the average daily volume of 8,566,910 shares. The stock had previously closed at $11.41.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on HLN shares. Hsbc Global Res downgraded Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. HSBC reissued a "hold" rating on shares of Haleon in a research note on Wednesday, March 5th. Morgan Stanley raised Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective for the company in a research note on Friday, May 9th. BNP Paribas Exane upgraded Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target for the company in a report on Tuesday, May 27th. Finally, BNP Paribas upgraded Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. Six investment analysts have rated the stock with a hold rating, four have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $12.33.

Haleon Price Performance

The stock has a market cap of $49.98 billion, a P/E ratio of 32.65, a P/E/G ratio of 2.82 and a beta of 0.31. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The business has a 50 day simple moving average of $10.46 and a 200-day simple moving average of $10.01.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. FMR LLC lifted its position in shares of Haleon by 3.7% during the 4th quarter. FMR LLC now owns 108,827,814 shares of the company's stock valued at $1,038,217,000 after buying an additional 3,909,545 shares during the last quarter. Wellington Management Group LLP lifted its position in shares of Haleon by 22.0% during the 1st quarter. Wellington Management Group LLP now owns 18,700,480 shares of the company's stock valued at $192,428,000 after buying an additional 3,372,155 shares during the last quarter. Sculptor Capital LP lifted its position in shares of Haleon by 22.1% during the 1st quarter. Sculptor Capital LP now owns 10,849,868 shares of the company's stock valued at $111,645,000 after buying an additional 1,962,770 shares during the last quarter. Envestnet Asset Management Inc. lifted its holdings in Haleon by 0.8% during the 4th quarter. Envestnet Asset Management Inc. now owns 7,630,307 shares of the company's stock worth $72,793,000 after purchasing an additional 58,444 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in Haleon by 18.3% during the 4th quarter. JPMorgan Chase & Co. now owns 6,014,903 shares of the company's stock valued at $57,382,000 after buying an additional 930,701 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company's stock.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.